Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Disability worsening · people with multiple sclerosis

Siponimod may leads to lower participants with disability worsening at 6 months compared with placebo (low certainty).

1 finding from 1 review

Siponimod for multiple sclerosis 2021 · Cochrane Headline outcomes only
RR 0.78 [0.65, 0.94]
1 study · 1641 participants
Low